DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
34 hedge funds and large institutions have $988K invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
34
Holding in Top 10
–
Calls
$40K
Puts
–
Top Buyers
| 1 | +$75.7K | |
| 2 | +$51K | |
| 3 | +$12.6K | |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$2.54K |
| 5 |
SC
Shay Capital
New York
|
+$1.35K |
Top Sellers
| 1 | -$93K | |
| 2 | -$7.28K | |
| 3 | -$2.93K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.71K |
| 5 |
Jane Street
New York
|
-$923 |